Literature DB >> 23715864

BMP-2 differentially modulates FGF-2 isoform effects in osteoblasts from newborn transgenic mice.

Maria Giovanna Sabbieti1, Dimitrios Agas, Luigi Marchetti, J Douglas Coffin, Liping Xiao, Marja M Hurley.   

Abstract

We previously generated separate lines of transgenic mice that specifically overexpress either the Fibroblast growth factor (FGF)-2 low-molecular-mass isoform (Tg(LMW)) or the high-mass isoforms (Tg(HMW)) in the osteoblast lineage. Vector/control (Tg(Vector)) mice were also made. Here we report the use of isolated calvarial osteoblasts (COBs) from those mice to investigate whether the FGF-2 protein isoforms differentially modulate bone formation in vitro. Our hypothesis states that FGF-2 isoforms specifically modulate bone morphogenetic protein 2 (BMP-2) function and subsequently bone differentiation genes and their related signaling pathways. We found a significant increase in alkaline phosphatase-positive colonies in Tg(LMW) COBs compared with Tg(Vector) controls. BMP-2 treatment significantly increased mineralized colonies in Tg(Vector) and Tg(LMW) COBs. BMP-2 caused a further significant increase in mineralized colonies in Tg(LMW) COBs compared with Tg(Vector) COBs but did not increase alkaline phosphatase-positive colonies in Tg(HMW) COBs. Time-course studies showed that BMP-2 caused a sustained increase in phosphorylated mothers against decapentaplegic-1/5/8 (Smad/1/5/8), runt-related transcription factor-2 (Runx-2), and osterix protein in Tg(LMW) COBs. BMP-2 caused a sustained increase in phospho-p38 MAPK in Tg(Vector) but only a transient increase in Tg(LMW) and Tg(HMW) COBs. BMP-2 caused a transient increase in phospho-p44/42 MAPK in Tg(Vector) COBs and no increase in Tg(LMW) COBs, but a sustained increase was found in Tg(HMW) COBs. Basal expression of FGF receptor 1 protein was significantly increased in Tg(LMW) COBs relative to Tg(Vector) COBs, and although BMP-2 caused a transient increase in FGF receptor 1 expression in Tg(Vector) COBs and Tg(HMW) COBs, there was no further increase Tg(LMW) COBs. Interestingly, although basal expression of FGF receptor 2 was similar in COBs from all genotypes, BMP-2 treatment caused a sustained increase in Tg(LMW) COBs but decreased FGF receptor 2 in Tg(Vector) COBs and Tg(HMW) COBs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23715864      PMCID: PMC3713219          DOI: 10.1210/en.2013-1025

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  47 in total

Review 1.  Transcription factors in bone: developmental and pathological aspects.

Authors:  Xiangli Yang; Gerard Karsenty
Journal:  Trends Mol Med       Date:  2002-07       Impact factor: 11.951

2.  BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2.

Authors:  Mi-Hye Lee; Tae-Geon Kwon; Hyo-Sang Park; John M Wozney; Hyun-Mo Ryoo
Journal:  Biochem Biophys Res Commun       Date:  2003-09-26       Impact factor: 3.575

3.  High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons.

Authors:  H Prats; M Kaghad; A C Prats; M Klagsbrun; J M Lélias; P Liauzun; P Chalon; J P Tauber; F Amalric; J A Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

Review 4.  Generation of protein isoform diversity by alternative initiation of translation at non-AUG codons.

Authors:  Christian Touriol; Stéphanie Bornes; Sophie Bonnal; Sylvie Audigier; Hervé Prats; Anne-Catherine Prats; Stéphan Vagner
Journal:  Biol Cell       Date:  2003 May-Jun       Impact factor: 4.458

5.  A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome.

Authors:  Yukiho Tanimoto; Masahiko Yokozeki; Kenji Hiura; Kazuya Matsumoto; Hideki Nakanishi; Toshio Matsumoto; Pierre J Marie; Keiji Moriyama
Journal:  J Biol Chem       Date:  2004-08-13       Impact factor: 5.157

6.  Human basic fibroblast growth factor gene encodes four polypeptides: three initiate translation from non-AUG codons.

Authors:  R Z Florkiewicz; A Sommer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

7.  Effect of overexpressing fibroblast growth factor 2 protein isoforms in osteoblastic ROS 17/2.8 cells.

Authors:  L Xiao; P Liu; T Sobue; A Lichtler; J D Coffin; M M Hurley
Journal:  J Cell Biochem       Date:  2003-08-15       Impact factor: 4.429

Review 8.  Multiple signaling pathways converge on the Cbfa1/Runx2 transcription factor to regulate osteoblast differentiation.

Authors:  Renny T Franceschi; Guozhi Xiao; Di Jiang; Rajaram Gopalakrishnan; Shuying Yang; Elizabeth Reith
Journal:  Connect Tissue Res       Date:  2003       Impact factor: 3.417

9.  Functional analysis of RUNX2 mutations in Japanese patients with cleidocranial dysplasia demonstrates novel genotype-phenotype correlations.

Authors:  Taketoshi Yoshida; Hirokazu Kanegane; Motomi Osato; Masatoshi Yanagida; Toshio Miyawaki; Yoshiaki Ito; Katsuya Shigesada
Journal:  Am J Hum Genet       Date:  2002-08-26       Impact factor: 11.025

10.  Human basic fibroblast growth factor: nucleotide sequence and genomic organization.

Authors:  J A Abraham; J L Whang; A Tumolo; A Mergia; J Friedman; D Gospodarowicz; J C Fiddes
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

View more
  12 in total

1.  microRNA-375 inhibits osteogenic differentiation by targeting runt-related transcription factor 2.

Authors:  Feiya DU; Huiling Wu; Zhiqin Zhou; Y U Liu
Journal:  Exp Ther Med       Date:  2015-05-07       Impact factor: 2.447

Review 2.  TGF-β Family Signaling in Mesenchymal Differentiation.

Authors:  Ingo Grafe; Stefanie Alexander; Jonathan R Peterson; Taylor Nicholas Snider; Benjamin Levi; Brendan Lee; Yuji Mishina
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

Review 3.  A nuclear odyssey: fibroblast growth factor-2 (FGF-2) as a regulator of nuclear homeostasis in the nervous system.

Authors:  Benjamin Förthmann; Claudia Grothe; Peter Claus
Journal:  Cell Mol Life Sci       Date:  2015-01-01       Impact factor: 9.261

4.  Fibroblast growth factor-2 isoform (low molecular weight/18 kDa) overexpression in preosteoblast cells promotes bone regeneration in critical size calvarial defects in male mice.

Authors:  Liping Xiao; Daisuke Ueno; Sylvain Catros; Collin Homer-Bouthiette; Lyndon Charles; Liisa Kuhn; Marja M Hurley
Journal:  Endocrinology       Date:  2014-01-09       Impact factor: 4.736

5.  Plasmid DNA-coding p62 as a bone effective anti-inflammatory/anabolic agent.

Authors:  Maria Giovanna Sabbieti; Dimitrios Agas; Melania Capitani; Luigi Marchetti; Antonio Concetti; Cecilia Vullo; Giuseppe Catone; Vladimir Gabai; Victor Shifrin; Michael Y Sherman; Alexander Shneider; Franco M Venanzi
Journal:  Oncotarget       Date:  2015-02-28

Review 6.  Fibroblast growth factor signaling in skeletal development and disease.

Authors:  David M Ornitz; Pierre J Marie
Journal:  Genes Dev       Date:  2015-07-15       Impact factor: 11.361

7.  Synergistic induction of early stage of bone formation by combination of recombinant human bone morphogenetic protein-2 and epidermal growth factor.

Authors:  Jae Hyup Lee; Soo-Jeong Jang; Hae-Ri Baek; Kyung Mee Lee; Bong-Soon Chang; Choon-Ki Lee
Journal:  J Tissue Eng Regen Med       Date:  2014-04-25       Impact factor: 3.963

8.  Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography.

Authors:  Natalia Platonova; Géraldine Miquel; Liang-Yuan Chiu; Said Taouji; Elisabetta Moroni; Giorgio Colombo; Eric Chevet; Shih-Che Sue; Andreas Bikfalvi
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

9.  The Effects of Photobiomodulation of 808 nm Diode Laser Therapy at Higher Fluence on the in Vitro Osteogenic Differentiation of Bone Marrow Stromal Cells.

Authors:  Andrea Amaroli; Dimitrios Agas; Fulvio Laus; Vincenzo Cuteri; Reem Hanna; Maria Giovanna Sabbieti; Stefano Benedicenti
Journal:  Front Physiol       Date:  2018-02-23       Impact factor: 4.566

10.  Fibroblast growth factor receptor 3 interacts with and activates TGFβ-activated kinase 1 tyrosine phosphorylation and NFκB signaling in multiple myeloma and bladder cancer.

Authors:  Lisa Salazar; Tamara Kashiwada; Pavel Krejci; April N Meyer; Malcolm Casale; Matthew Hallowell; William R Wilcox; Daniel J Donoghue; Leslie Michels Thompson
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.